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A B S T R A C T
An outbreak of skin ulcers with morbidity and mortality rate of 80% and 20% respectively, among Genetically
Improved Farmed Tilapia (GIFT) sub-adults reared in a brackish water ﬂoating cage farm of Kochi, Kerala, India
was reported. Bacterial isolation attempts from various internal organs (blood, kidney, liver, spleen and brain) of
diﬀerent diseased ﬁsh indicated a common bacterial etiology. Organisms were identiﬁed as Vibrio vulniﬁcus
based on conventional microbiological methods followed by molecular conﬁrmation. Additionally, V. vulniﬁcus
marker speciﬁc for ﬁsh virulence was present in the isolates. Fish pathogenicity was conﬁrmed by challenge
tests. LD50 was calculated as 2.1×105.13 CFU/ﬁsh and 2.1×106.12 CFU/mL in injection and immersion route
respectively. pilF polymorphism-based PCR and vvhA gene sequence indicated potential danger for humans. The
strain was positive for siderophore, hemolysin, capsule, polar and lateral ﬂagella. The strain could multiply
rapidly in healthy ﬁsh serum. All these results indicated that the isolate could act as a primary pathogen for
tilapia ﬁsh. Interestingly, serum survival ratio of the pathogen was signiﬁcantly larger at higher temperatures
(p≤ .05); which may explain the increase in infective capacity of V. vulniﬁcus at higher temperature. Multiple
antibiotic resistance index of the strain was ≤0.2. In conclusion, the paper provides detailed descriptions of
clinical signs, microscopic and macroscopic lesions of a natural disease outbreak among tilapia raised in brackish
water cage farms of India. The concurrent attempts to identify and characterize the etiology fetches the basis for
future development of eﬀective control and preventive measures against V. vulniﬁcus, the most infectious and
lethal of all zoonotic vibrios.
1. Introduction
Aquaculture is the fastest growing food production sector in the
world (FAO, 2018). As aquaculture through cage farming oﬀers 70
times more production than ponds, the same is getting popularized
globally (Rutaisire et al., 2009; Mugamire et al., 2013). Cage culture of
ﬁsh in marine or brackish water environments holds a considerable
potential for enhancing aquaculture production in arid and tropical
coastal areas where seawater is abundant, sparing freshwater resources
for agriculture and other human activities (McGeachin et al., 1987;
Watanabe et al., 1989). Genetically Improved Farmed Tilapia (GIFT)
(Oreochromis niloticus L.) are excellent candidates for aquaculture in
oﬀshore cage farms due to their ability to withstand wide range of
salinity (El-Sayed, 2006). Accordingly, The ICAR-Central Marine Fish-
eries Research Institute (ICAR-CMFRI), Kochi, India, has initiated a
number of research and development programs on farming of this ﬁsh
strain in brackish water cages as a viable farming option during south-
west monsoon season in Kerala (Imelda et al., 2014). Nevertheless,
limited data are available on their diseases in such cages.
Modern techniques of intensive and super-intensive farming systems
have signiﬁcantly increased the incidences of infectious diseases in
commercial aquaculture systems (Mukherjee, 2002). Among infectious
agents, bacterial diseases are reported to be the largest single cause of
economic losses in aquaculture (Zhou et al., 2009; Stentiford et al.,
2012). Vibriosis is one of the major devastating diseases of ﬁsh causing
high mortalities and severe economic losses to cage aquaculture
https://doi.org/10.1016/j.aquaculture.2019.734217
Received 6 September 2018; Received in revised form 4 June 2019; Accepted 10 June 2019
⁎ Corresponding author.
E-mail addresses: reshma.kj@icar.gov.in, sumithra.g@icar.gov.in (K.J. Reshma).
1 Present address: Scientist, Marine Biotechnology Division, ICAR- Central Marine Fisheries Research Institute, Post Box No. 1603, Ernakulam North P.O., Kochi-
682 018.
Aquaculture 511 (2019) 734217
Available online 11 June 2019
0044-8486/ © 2019 Elsevier B.V. All rights reserved.
T
systems of marine or brackish water environments (Samuelsson et al.,
2006; Sarjito et al., 2009; Chatterjee and Haldar, 2012). However, only
a few Vibrio species such as V. anguillarum, V. alginolyticus, V. vulniﬁcus,
V. ordalii and V. salmonicida are reported to be economically important
in aquaculture (Sandlund et al., 2010). Among these, V. vulniﬁcus is
noteworthy since it causes severe disease in humans, ﬁsh, and shrimps
(Chen et al., 2006). This bacterium is considered the most infectious
and lethal of all human pathogenic vibrios and has become a serious
concern (Levin, 2005).
Fish-pathogenic V. vulniﬁcus was initially isolated from Japanese eel
in 1975 (Muroga et al., 1976). Later, epizootics of V. vulniﬁcus infection
were described among tilapia (Sarotherodon niloticus) of saltwater pens
in Japan (Sakata and Hattori, 1988) at 18-20 °C. Fouz et al. (2002)
showed that tilapia (O. niloticus) were susceptible to experimental
challenge with eel-pathogenic V. vulniﬁcus. Fouz and Amaro (2003)
reported two outbreaks of V. vulniﬁcus among freshwater eel farms of
Spain. Later, Shoemaker et al. (2011) characterized V. vulniﬁcus isolate
from diseased hybrid tilapia (O. niloticus × O. aureus) of USA. A de-
tailed description of a natural infection caused by V. vulniﬁcus in tilapia
ﬁsh cultured at Indian brackish water cage farm has been presented in
this paper. This forms the ﬁrst report of a natural and experimental
infection caused by V. vulniﬁcus in ﬁsh cultured in brackish water cage
farm of India. Further, microbiological, molecular and virulence char-
acteristics of the pathogen was comprehensively documented.
2. Materials and methods
2.1. Natural outbreak
Two thousand tilapia ﬁsh and one thousand Pearl spots (Etroplus
suratensis) were maintained in square shaped high density polyethylene
ﬂoating cage (6m×6m×1½m) moored in a brackish water eco-
system oﬀ Kochi, Kerala, India (latitude: 9° 85′ N; longitude 76° 38′ E)
(Fig. 1). Similar types of two cages were moored in the same location in
which mangrove red snapper (Lutjanus argentimaculatus) were stocked.
Fish were fed with commercial dry pellet (Growel) three times daily. A
cumulative mortality of 20% was recorded within one-week period
after 9months initial stocking with hemorrhagic lesions and ulcers on
the skin among tilapia ﬁsh (598.44 ± 56.05 g weight) during January
2018. The aﬀected ﬁsh were reported to show the clinical signs of
surfacing, anorexia, corneal opacity, erratic swimming behavior, lateral
recumbency and ﬁnally acute mortality. There was no mortality or
abnormal signs in other two species of ﬁsh. After recording tempera-
ture, pH and salinity of the resident water, moribund ﬁsh showing gross
clinical signs were transported in live condition to Fish Microbiology
laboratory, Marine Biotechnology Division, ICAR-CMFRI for further
investigations. Sampling was done in accordance with USFWS/AFS-FHS
(2004).
2.2. Necropsy examination
After recording gross external and internal lesions, wet impression
smears were taken from skin and gill to know the presence of any
parasites. Blood, liver, kidney and spleen were aseptically excised and
homogenized in sterile normal saline solution. Blood and tissue
homogenates were directly streaked on Zobell Marine Agar (ZMA;
Himedia), Brain Heart Infusion Agar (BHIA; Himedia), 1/10th strength
nutrient agar (NA; Himedia) and Thiosulphate Citrate Bile Salt Sucrose
agar (TCBS; Himedia). Inoculated plates were kept for incubation at
28 °C, and the colonies formed were picked and streaked onto ZMA
plate and incubated further. The isolates were stored as ZMA slants at
4 °C and as glycerol stocks at -80 °C. Morphological and major bio-
chemical characters were investigated based on Bergey's Manual of
Systematic Bacteriology (Bergey et al., 2012) for the preliminary
identiﬁcation of pathogen. Infected ﬁsh tissue samples were also
screened for the presence of 2 viral pathogens of tilapia namely,
betanodavirus and Tilapia lake virus by PCR (Bigarre et al., 2009;
Eyngor et al., 2014). As the preliminary identiﬁcation methods tenta-
tively indicated the infective bacteria as V. vulniﬁcus, molecular con-
ﬁrmation of the isolates were done by PCR ampliﬁcation using species
speciﬁc primers (Kaysner and DePaola, 2004) with minor modiﬁca-
tions. The cycling conditions were 94 °C for 5min, 30 cycles of 94 °C for
30 s, 55 °C for 30 s and 72 °C for 1min followed by 72 °C for 10min. The
ampliﬁcation products were veriﬁed by the presence of the desired
band (519 bp) on 1% agarose gel. Further, PCR was performed using
primers targeting V. vulniﬁcus virulence markers speciﬁc for ﬁsh viru-
lent strains (Sanjuan and Amaro, 2007) with minor modiﬁcations. The
cycling conditions were 94 °C for 5min, 35 cycles of 94 °C for 30 s, 60 °C
for 1min and 72 °C for 1min 30 s followed by 72 °C for 10min. The
amplicons were veriﬁed by running on 1.5% agarose gel and sequen-
cing of the representative amplicon. The sequence was then submitted
to GenBank database under accession number MK751426.
2.3. Histopathology
Representative samples of liver, spleen and gill from diseased ﬁsh
were ﬁxed in 10% neutral buﬀered formalin (NBF) for histopathology.
Tissues were processed using routine methods and embedded in par-
aﬃn wax. The sections cut 4 μM thickness were then stained using
haematoxylin and eosin (H&E) (Sharma et al., 2013).
2.4. Challenge experiments
2.4.1. Experimental ﬁsh
Apparently healthy juvenile ﬁsh (O. niloticus) with a mean weight of
15 g (10 to 20 g) were used for the challenge study. Fish were brought
from an aquaculture facility and maintained in oval shaped FRP tanks
containing 210 L of de-chlorinated, and continuously aerated water
having a salinity of 12 ppt and temperature of 25 ± 2ﹾC for 2 weeks.
The ﬁsh were fed ad libitum with ﬂoating pellet feed and 30% water
exchange was made on daily basis. Ammonia level was checked daily
and maintained below optimum. The animals were allowed to accli-
matize for 2 weeks; active feeding was noted for ﬁsh after the ﬁrst
week. Before beginning each experiment, three ﬁsh were randomly
necropsied, blood, cranial kidney and spleen were collected for bac-
teriological examination to rule out the presence of any bacterial in-
fection (Pretto-Giordano et al., 2010). All ﬁsh sampled in this study
were handled in strict accordance with the guidelines for the care and
use of ﬁsh in research by De Tolla et al. (1995) and the protocols were
approved by ICAR- Central Marine Fisheries Research Institute, Kochi,
India. All experiments were performed in triplicates to maintain the
consistency of the results. In all the experiments, clinical signs of
moribund ﬁsh were recorded, and dead ﬁsh were subjected to gross
pathological and bacteriological examination immediately after death.
For bacteriological examination, samples of blood, brain, liver, spleen
and kidney were aseptically plated on TCBS agar. The obtained colonies
were conﬁrmed biochemically and molecularly as V. vulniﬁcus (Kaysner
and DePaola, 2004). Mortalities were considered only if the challenged
strain was re-isolated in pure form from challenged ﬁsh (Amaro et al.,
1992).
2.4.2. Testing for pathogenicity through experimental infection
Representative isolate from the infected ﬁsh (named as CMFRI/VV-
02) was inoculated into fresh LB broth with 1% NaCl and incubated at
28 °C with shaking for 18 h, followed by centrifugation (10, 000 rpm for
20min at 4 °C) and re-suspension in sterilized PBS. During the chal-
lenge experiments, the ﬁsh were maintained in glass tanks containing
40 L of ﬁltered water (salinity-12 ppt; temperature 25 ± 2ﹾC) with
continuous aeration. The experimental ﬁsh were randomly divided into
four groups (two infected groups and two control groups, six ﬁsh per
tank; each group in triplicates) and used for testing the pathogenicity of
the isolate. The ﬁrst group was injected intramuscularly with 0.1 mL of
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the bacterial suspension containing 1010 CFU/mL. The second batch
was injected with 0.1mL of sterile PBS to form the control group for
injection challenge. The third group was maintained in glass aquaria to
which the bacterial suspension was loaded to reach a ﬁnal concentra-
tion of 108 CFU/mL. The forth group was maintained as a control for
immersion challenge. All the ﬁsh were monitored for 14 days.
2.4.3. Determination of LD50 through injection challenge
Tenfold serial dilutions of the bacterial suspension (prepared as
above) were made in sterile PBS. A dose range of 2.1× 101 to
2.1×108 CFU/ﬁsh was then used to ﬁnd out the minimum dose re-
quired for causing 50% mortality through injection challenge.
Experimental ﬁsh were maintained in 14 glass tanks containing 40 L of
ﬁltered water (salinity-12 ppt; temperature 25 ± 2ﹾC) with continuous
aeration. Each tank contained six ﬁsh with triplicate tanks for each
dose. The ﬁsh were injected intramuscularly with 0.1 mL of the bac-
terial suspension containing 2.1× 102–2.1× 109 CFU/mL. Control ﬁsh
were injected with 0.1 mL of sterile PBS. All ﬁsh were monitored for
10 days and mortalities recorded. Afterwards, LD50 was calculated as
per Reed and Muench (1938).
2.4.4. Determination of LD50 through immersion challenge
Tenfold serial dilutions of the bacterial suspension (prepared as
above) were prepared in sterile PBS and placed into the water tanks
containing 40 L of ﬁltered water (salinity-12 ppt; temperature
25 ± 2ﹾC) with continuous aeration, at ﬁnal concentrations of
2.1× 103–2.1×109 CFU/mL. Each tank contained six ﬁsh with tri-
plicate tanks for each dose. Immersion infection was conducted as per
Lavilla-Pitogo et al. (1992). Healthy tilapia juveniles were randomly
divided into 8 groups (seven infected groups and one control group, six
ﬁsh per group, each group in triplicates) and challenged by immersion.
Fish were maintained in the various concentrations of bacterial sus-
pensions described above for 14 days. Fish in the control group were
placed in ﬁltered water (salinity-12 ppt; temperature 25 ± 2ﹾC) for
14 days. During the period of immersion, no food was provided, and the
water was not renewed to maintain the stable water environment and
bacterial concentration. The experimental ﬁsh were observed daily, and
disease signs and death status were recorded. Afterwards, LD50 was
calculated as Reed and Muench (1938).
2.5. Molecular characterization by 16S rRNA gene sequencing
Genomic DNA was extracted from the representative isolate by
CTAB method (Wilson, 1987) and 16S rRNA gene (~1500 bp) was
ampliﬁed using universal bacterial primers, NP1F 5’GAGTTTGATCCT
GGCTCA-3′ and NP1R 5’-ACGGCTACCTTGTTACGACTT- 3′ (Nair et al.,
2012). The amplicons were Sanger sequenced at a custom DNA se-
quencing facility (Agrigenome, India). The sequence was subjected to
homology search using NCBI-BLAST. The overlapping 820 bp fragment
of 16S rRNA gene from both sequencing reactions was then aligned
using ClustalW and a phylogenetic tree was constructed by neighbor-
joining method (MEGA version 7 software) using Kimura 2-parameter
model (selected based on its lowest BIC score, Bayesian information
criterion) (Kumar et al., 2016). The corresponding sequence of V.
parahaemolyticus was used as an out-group for rooting trees. The con-
ﬁdence in NJ tree was estimated by 1000 bootstrap replicates. Nu-
cleotide sequence of 16S rRNA gene from CMFRI/VV-02 strain was
submitted to GenBank database under accession number MH355960.
Fig. 1. Sampling location of the present study.
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2.6. Screening for virulence determinants
The presence of various factors associated with virulence of V. vul-
niﬁcus namely, haemolysin, protease, siderophore, capsule and ﬂagella
was checked in the representative isolate (CMFRI/VV-02). For haemo-
lysin detection, strains were streaked on nutrient agar enriched with 5%
bovine blood. Plates were incubated for 24 h at 37 °C, and checked for
the presence of hemolysis halos (Moreno and Landgraf, 1998). Pro-
teolytic activity was detected by spotting bacteria on nutrient agar
containing 2% concentration of skim milk. After incubation at 37 °C for
24–48 h, formation of a clear halo around the culture spot was checked
(Moreno and Landgraf, 1998). To demonstrate the presence of side-
rophore, the bacteria was spotted onto the surface of Chrome azurol S
(CAS) agar and incubated for 24 h at 37 °C. The formation of yellow-
orange halo aroud the culture spot was observed (Schwyn and Neilands,
1987). The presence of capsule was tested by India ink staining. The
existence of polar and lateral ﬂagella, involved in swimming and
swarming movements was also tested. For swimming, the isolate was
plated on Brain Heart Infusion Agar (BHI; Himedia) with 2% sodium
chloride and 0.3% agar and incubated at 37 °C for 24 h. For swarming,
the isolate was inoculated into BHI agar plates with 1% agar and in-
cubated for 48 h at 37 °C (Natividad-Bonifacio et al., 2013).
2.7. Tolerance to environmental variables
Ability of the representative isolate (CMFRI/VV-02) to tolerate
diﬀerent environmental variables namely, temperature, pH and salinity
was done by checking the presence or absence of growth at varying
temperature (4–50 °C), salinity (0–10%) and pH (1–14) for 24–72 h.
2.8. Bacterial survival in serum
Survival of the representative isolate (CMFRI/VV-02) in healthy
naïve tilapia serum was measured. Brieﬂy, bacterial cell suspensions in
PBS (107 CFU/mL) were incubated in serum samples (pooled from 4 to
6 ﬁsh) with duplicates and incubated at 25 °C, 28 °C and 32 °C for 4 h.
Bacterial cell suspension incubated in PBS under diﬀerent temperature
acted as control for each experiments. Afterwards, viable cell counts
were found out by drop-plating the serial dilutions on ZMA plates (Fouz
et al., 2002).
2.9. vvhA gene sequence analysis
Representative amplicon (vvhA gene) obtained during the molecular
conﬁrmation step using species speciﬁc primers (Kaysner and DePaola,
2004) was puriﬁed and sequenced at Agrigenome, India. The sequence
was then submitted to GenBank database under accession number
MH357338. The overlapping 455 fragment of vvhA gene from both
sequencing reactions was then aligned against other V. vulniﬁcus strains
using CLUSTAL-W and the aligned data set was used for the vvhA group
identiﬁcation and as the input for phylogenetic analysis. In phyloge-
netic analysis, vvhA gene sequence of strain L-180 (a group 1 strain
from human blood) and CDC B3547 (a group 2 strain from human leg
ulcer) (Senoh et al., 2005) was also included. The analysis was done by
neighbor-joining method (MEGA version 7 software) using Kimura 2-
parameter model (Kumar et al., 2016) with the conﬁdence in NJ tree
estimated by 1000 bootstrap replicates.
2.10. pilF polymorphism-based PCR
To ascertain public heath signiﬁcance of the ﬁsh pathogen in the
present outbreak, a pilF gene based PCR targeting the variable region
associated with potential human pathogenicity, was performed using
speciﬁc primers (Roig et al., 2010) and pfu enzyme. The cycling con-
ditions were 95 °C for 2min, 35 cycles of 95 °C for 20 s, 65 °C for 40 s
and 72 °C for 2min followed by 72 °C for 5min. The speciﬁc
ampliﬁcations were veriﬁed by the presence of desired band on 1.5%
agarose gel and sequencing.
2.11. Antibiotic susceptibility test
In-vitro antibiotic susceptibility of the representative isolate
(CMFRI/VV-02) to 23 antibiotics belonging to 9 diﬀerent classes
(HiMedia Laboratories, Mumbai, India) was analyzed using disc diﬀu-
sion test as recommended by Clinical and Laboratory Standard Institute
(CLSI, 2018) antimicrobial susceptibility testing. Inhibition zones were
measured and the antimicrobial susceptibility of strain was determined.
E. coli ATCC25922 was run in parallel as a reference strain for antibiotic
susceptibility test. Established criteria for Vibrio vulnifcus by WHO was
used for interpretation as either susceptible, intermediate, or resistant
using WHONET (http://www.whonet.org) version 5.6. Multiple anti-
biotic resistance (MAR) index was calculated using the formula MAR
index=X/Y, where ‘X' represents the number of antibiotics to which
the isolate showed resistance and ‘Y' represents the total number of
antibiotics to which the isolate was evaluated (Krumperman, 1983).
2.12. Statistical analysis
One-way ANOVA followed by post-hoc Tukey's HSD test was used to
compare the bacterial survival ratio in naive ﬁsh serum at diﬀerent
temperatures. Value of P < .05 was set to represent signiﬁcant dif-
ference. Statistical analyses were carried out using SPSS (SPSS Inc. IL,
Chicago) Version 16.
3. Results
3.1. Gross observations
Hydrographic parameters of cage water were as follows: Salinity-
12 ppt, temperature-31 °C and pH -7.1. Many of the diseased ﬁsh in
stock showed dark discoloration of skin, a characteristic deep ulcer
exposing the underlying muscle below dorsal skin (Fig. 2a) and external
hemorrhages on ﬁns (Fig. 2b). Eyes revealed corneal opacity (Fig. 2c).
Redness or erythematous patches were observed on lower abdomen and
lower mandibular region. Blood was pale and watery. Gills were pale.
In several ﬁsh, abdomen was distended with yellowish transparent
gelatinous peritoneal ﬂuid. Internally, the lesions were as follows;
generalized fat accumulation in the abdominal cavity, pale liver with
congested blood vessels, congested mucosa of stomach, yellowish
transparent gelatinous ﬂuid ﬁlled intestine, engorged gall bladder,
congested and enlarged kidneys and splenomegaly.
3.2. Screening for parasitic and viral pathogens
PCR ampliﬁcation for detection of tilapia lake virus and betanodavirus
did not yield any products. Macroscopic and microscopic examination
of gill and body surfaces of the diseased ﬁsh, did not show any parasites
and protozoans.
3.3. Bacterial isolation and characterization
From the naturally infected moribund ﬁsh less opaque, small to
medium sized bacterial colonies and green opaque colonies were iso-
lated on ZMA/BHIA and TCBS agar plates respectively, from blood,
liver, kidney and spleen samples. There was no growth in 1/10th-
strength nutrient agar. Bacterial isolation attempts from diﬀerent dis-
eased ﬁsh gave morphologically similar isolates, indicating a common
bacterial etiology in the stock. Based on conventional microbiological
methods and PCR using species speciﬁc primers, the infective bacteria
were identiﬁed as V. vulniﬁcus. On PCR ampliﬁcation of vvhA gene
encoding haemolysin, an expected amplicon of ~519 bp was obtained
with all the isolates. Further, there was ampliﬁcation of speciﬁc ﬁsh
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virulent sequences by PCR and the speciﬁc ampliﬁcation was conﬁrmed
by sequencing of the representative amplicon (GenBank Accession
number MK751426) (Fig. 3).
3.4. Histopathology
Hemorrhage was the consistent microscopic ﬁnding in all the tissues
examined. Additionally, hepatic parenchyma revealed fatty changes,
vascular engorgement due to active congestion (Fig. 4a), degeneration
and necrotic areas among perivascular hepatocytes, and hypertrophic
changes in biliary epithelium (Fig. 4b). In a few places, necrotic he-
patocytes were replaced by erythrocytes (Fig. 4c). Increased deposits of
hemosiderin could be observed throughout splenic parenchyma
(Fig. 4d). There were hyperplastic changes in gill with mild to extensive
hyperplasia leading to fusion of secondary lamellae.
3.5. Challenge experiments
Koch's postulate was conﬁrmed by the experimental infection and
re-isolation from the moribund ﬁsh (blood, liver, brain, kidney and
spleen) through injection and immersion challenge. The mortality was
100% in both challenge experiments. At the same time, no bacteria
could be isolated from control group. All the infected ﬁsh died between
24 and 48 h after injection challenge and within 3–5 days after im-
mersion challenge. Fish infected by both routes showed reduced ap-
petite, surfacing, dark coloration of skin, imbalance, less activity,
exophthalmia and ascites. The blood was pale and watery. The gross
lesions observed were; ascites (Fig. 5a), petechiae on skin (Fig. 5b),
hemorrhages on ﬁns (Fig. 5c, d) and exophthalmia. Internal organs
showed generalized hemorrhages, renal fragility, splenomegaly, dark
red discoloration of the liver and engorged gall bladder. Gastric and
intestinal lumen were ﬁlled with yellowish gelatinous ﬂuid. No external
or internal parasites and ulcers were observed.
3.6. Determination of LD50
LD50 value of V. vulniﬁcus was found to be 2.1×105.13 CFU/ﬁsh
and 2.1×106.12 CFU/mL in injection and immersion challenge re-
spectively. Cumulative mortality percentage of tilapia juveniles chal-
lenged with diﬀerent doses of V. vulniﬁcuswithin 10 days and 14 days in
injection and immersion challenge respectively was represented in
Fig. 5. Brieﬂy, the isolated strain infected ﬁsh showed clinical signs and
mortality from day 2 and day 3 post-challenge in injection and im-
mersion challenge respectively. Cumulative mortality % at diﬀerent
CFUs of pathogen following immersion and injection challenge were
depicted in Fig. 6.
3.7. Phylogenetic analysis based on 16S rRNA gene sequence
Using BLAST search on GenBank in which 16S rRNA sequence
(MH355960.1) of CMFRI/VV-02 showed 100% homology to many V.
vulniﬁcus strains including the type strain (ATCC 27562) (Accession
number NR 117906) and the strain 93 U204 isolated from a diseased
Fig. 2. Macroscopic lesions observed during natural disease outbreak. Fig. 2a Characteristic deep ulcer exposing the underlying muscle below dorsal skin; Fig. 2b:
Hemorrhages on ﬁns; Fig. 2c: Corneal opacity.
Fig. 3. PCR ampliﬁcation of V. vulniﬁcus virulence marker speciﬁc for ﬁsh
virulent strains.
Lane M: GeneRuler™ 1 kb DNA Ladder, Lane 1: Negative control, Lane 2:
Speciﬁc ampliﬁcation product.
T.G. Sumithra, et al. Aquaculture 511 (2019) 734217
5
Hybrid tilapia in Taiwan (Accession number CP009261.1). The per-
centage similarity with 16S rRNA gene sequence of other closely related
Vibrio sp., such as V. diazotrophicus strain NBRC103148 (NR118930.1),
V. ﬂuvialis strain VL5125 (NR036790.1), V. anguillarum strain
NBRC13266 (NR113609.1) and V. ordalii strain ATCC33509
(NR044851.1) were 98%, 98%, 98% and 97% respectively.
Comparative phylogenetic tree analysis of CMFRI/VV-02 strain and
other Vibrio strains using 16S rRNA sequences was depicted in Fig. 7.
3.8. Screening of virulence determinants and tolerance to environmental
variables
CMFRI/VV-02 produced β hemolysis on blood agar within 48 h. The
strain was positive for capsule and siderophore production. It produced
swimming and swarming movements. However, it showed no protease
activity on skim milk agar. In the tests for tolerance to environmental
variables, the isolate could survive in a temperature range of 20-45 °C,
Fig. 4. Histopathology of tilapia infected with V. vulniﬁcus in natural disease outbreak. Fig. 4a Vascular engorgement in hepatic parenchyma H&E Bar= 50 μM;
Fig. 4b: Hypertrophic changes in biliary epithelium H&E Bar=10 μM; Fig. 4c: Replacement of necrotic hepatocytes by erythrocytes H&E Bar=100 μM; Fig. 4d:
Increased hemosiderin deposits in splenic parenchyma H&E Bar=10 μM.
Fig. 5. Macroscopic lesions observed during experimental challenge. Fig. 5a Ascites; Fig. 5b: Petechiae on skin; Fig. 5c: Hemorrhagic spot at base of pelvic ﬁn;
Fig. 5d: Hemorrhages on caudal ﬁn.
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salinity of 0–3% and pH of 6–10.
3.9. Bacterial survival in serum
CMFRI/VV-02 strain could survive and multiply in serum samples of
healthy tilapia ﬁsh. The bacterial survival at diﬀerent temperature was
given in Fig. 8. The bacterial survival ratio was higher at the end of the
incubation period compared to control in all the temperatures which
indicated that serum has not bacteriostatic or bactericidal activity
against CMFRI/VV-02 strain. One-way ANOVA showed that there was a
statistically signiﬁcant diﬀerence in serum survival ratio between
diﬀerent temperatures (p≤ .05). A Tukey post hoc test revealed serum
survival was statistically signiﬁcantly higher at 31 °C compared to 25 °C
and 28 °C (p≤ .05). There was no statistically signiﬁcant diﬀerence
between the survival at 25 °C and 28 °C (p= .646).
3.10. vvhA gene sequence analysis
vvhA sequence analysis was followed to identify the genetic group of
CMFRI/VV-02. The gene sequence of the strain (GenBank accession
number MH357338) showed 100% identity to V. vulniﬁcus group I
(L180 strain) using NCBI-BLAST search. It was 99% identical to that of
Fig. 6. Cumulative mortality % (CMR) of tilapia juveniles during experimental challenge at diﬀerent doses of V. vulniﬁcus. Fig. 6a CMR% after immersion challenge;
Fig. 6b: CMR % after injection challenge.
Error bars represent standard error.
Fig. 7. Neighbor-joining tree of V. vulniﬁcus CMFRI/VV-02 strain with other closely related Vibrio sp. based on 16S rRNA gene sequence.
Names of each bacteria including strain ID are followed by corresponding GenBank accession numbers.
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Tilapia strain from Taiwan (strain 93U204 with GenBank accession
number CP009262.1). CMFRI/VV-02 strain demonstrated 95% identity
with CDC B3547 (human strain) (GenBank accession number
AB124803.1) and CECT4999 (eel strain) (GenBank accession number
CP014637), both of which belonged to Group II. Comparative phylo-
genetic tree analysis of CMFRI/VV-02 strain and other V. vulniﬁcus
strains using vvhA sequences was portrayed in Fig. 9. There were clearly
two clades in which CMFRI/VV02 clustered along with group I which
also contained Taiwan tilapia strain 93 U204. The strains belonging to
group 2 (eel pathogenic strains) formed a diﬀerent clade. The branching
of both clades I and II was exceptionally strong, as indicated by the high
bootstrap value of 100%.
3.11. pilF polymorphism-based PCR
On PCR ampliﬁcation of pilF gene fragment, an expected amplicon
of ~338 bp was obtained (Fig. 10).
3.12. Antibiotic susceptibility test
In the antibiotic sensitivity test, the isolate was tested for its sus-
ceptibility to 23 antibiotics belonging to 9 diﬀerent classes. CMFRI/
Fig. 8. Survival ratio of CMFRI/VV-02 strain after 4 h of incubation within
naive tilapia serum compared to within PBS as control.
Error bars represent the standard error.
Fig. 9. Comparative phylogenetic tree analysis of CMFRI/VV-02 strain and other V. vulniﬁcus strains using vvhA sequence.
Names of each bacteria including strain ID are followed by corresponding GenBank accession numbers. V. vulniﬁcus strain of Hybrid tilapia from Taiwan was
represented by green colored bold letters and eel pathogenic strain was represented by pink colored bold letters. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 10. PCR ampliﬁcation of pilF gene fragment speciﬁc to V. vulniﬁcus strains
potentially dangerous for humans.
Lane M GeneRuler™ 1 kb DNA Ladder, Lane 1: Speciﬁc ampliﬁcation product
(338 bp); Lane 2: Negative control.
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VV02 strain was resistant or intermediately resistant only to 3 anti-
biotics namely, Cefoxitin (CK30), Colistin (CL10) and Cefuroxime
(CXM30) (Table 1). MAR index of the strain was 0.13.
4. Discussion
V. vulniﬁcus, a multi-host pathogen is a common worldwide in-
habitant of estuarine and marine ecosystems. It is commonly associated
with zooplankton, crabs, and various ﬁlter feeders such as oysters and
mussels. Simultaneously, V. vulniﬁcus is a highly invasive pathogen of
ﬁsh and humans. The organism is capable of causing rapidly fatal in-
fections in humans following ingestion or wound contamination
(Linkous and Oliver, 1999). Among ﬁsh, the pathogen is reported to
cause substantial economic losses to eel aquaculture industry of Asia
and Europe (Amaro et al., 1992). Simultaneously, V. vulniﬁcus causes
large epidemics of mortality in many other species of ﬁsh and the in-
fected ﬁsh shows severe hemorrhagic body lesions (Li et al., 2006).
Prevalence studies of V vulniﬁcus in India demonstrated its presence in
the waters and wild caught ﬁsh and shellﬁsh (Thampuran and
Surendran, 1998; Parvathi et al., 2004; Sangeetha et al., 2017). How-
ever, pathological signiﬁcance of V. vulniﬁcus in ﬁsh cultured in Indian
cage waters is not known till date.
Genetically Improved Farmed Tilapia (Oreochromis niloticus L.) are
reported as the excellent candidates for aquaculture in oﬀshore cage
farms due to their ability to tolerate a wide range of water salinity (El-
Sayed, 2006). Presently, most of the farming of tilapia in India is based
on fresh water. Recently, there is an increasing trend for the culture of
ﬁsh in brackish water cages (Imelda et al., 2014). Nevertheless, no data
are available on the diseases of ﬁsh cultured in brackish or marine
waters of India. The ﬁrst report of V. vulniﬁcus infection among ﬁsh
raised in a brackish water cage farm of India along with the detailed
characterization of pathogen was documented through the present
paper.
Outbreak of skin ulcers with mortality was recorded among tilapia
sub-adults in a brackish water ﬂoating cage farm oﬀ Kochi, Kerala,
India during January 2018. Total cumulative mortality was approx.
20% and morbidity rate was 80%. Aﬀected ﬁsh showed dark dis-
coloration of skin, surfacing, anorexia, corneal opacity, erratic swim-
ming behavior, hemorrhagic lesions and ulcers. All ﬁsh showed typical
septicemic changes during necropsy. The consistent histological lesion
seen in all organs was hemorrhagic in nature, with the most prominent
changes in liver. Water quality parameters were within optimal ranges
for aquaculture during the outbreak. Bacterial isolation attempts from
various internal organs (blood, kidney, liver and spleen) of diﬀerent
diseased ﬁsh indicated a common bacterial etiology in the stock. Based
on conventional microbiological methods the infective bacteria were
tentatively identiﬁed as V. vulniﬁcus. As phenotypic plasticity of V.
vulniﬁcus necessitate molecular validation (Harwood et al., 2004), the
bacterial identity was further conﬁrmed by PCR using species speciﬁc
primers (Kaysner and DePaola, 2004). Further, PCR targeting V. vulni-
ﬁcus virulent marker speciﬁc for ﬁsh-virulent strains was positive in the
isolates (Sanjuan and Amaro, 2007). The mortality rate, clinical signs,
macroscopic and microscopic lesions were compatible with other re-
ports of V. vulniﬁcus infections in European eels (Anguilla anguilla)
(Biosca et al., 1991), Trachinotus ovatus (Li et al., 2006), Nile tilapia (O.
niloticus) (Chen et al., 2006; Fouz et al., 2002; Sakata and Hattori, 1988)
and Epinephyelus sp. (Liu et al., 1994).
Since all the strains isolated from various internal organs of dif-
ferent diseased ﬁsh indicated a common etiology, further pathogenicity
studies were carried out using a representative strain (CMFRI/VV-02).
Challenge experiments showed that LD50 value was 2.1×105.13 CFU/
ﬁsh and 2.1× 106.123 CFU/mL in injection and immersion challenge
respectively. There was 100% mortality following challenge with
≥2.1× 107 CFU/ﬁsh and ≥2.1× 108 CFU/mL by injection and im-
mersion route respectively. We propose that CMFRI/VV-02 can behave
as a major pathogen for tilapia ﬁsh due to following three reasons.
Primarily, after intramuscular challenge the strain showed LD50 of
2.1× 105.13 CFU/ﬁsh. Secondly, this strain was virulent even by im-
mersion challenge; while other known tilapia pathogens like
Streptococcus sp., were incapable to infect ﬁsh unless skin was scariﬁed
prior to challenge (Chang and Plumb, 1996; Fouz et al., 2002). Thirdly,
the isolate eﬃcaciously multiplied in healthy ﬁsh serum compared to
control. This resistance to ﬁsh serum is essential for spreading of bac-
teria to main body organs (Amaro et al., 1997). Thus the results cor-
related with isolation of bacteria from various organs (blood, brain,
liver, spleen and kidney) in both natural outbreak and challenge tests.
Another noteworthy observation was there was a statistically sig-
niﬁcant diﬀerence in serum survival ratio between diﬀerent tempera-
tures (p≤ .05). A Tukey post hoc test revealed serum survival was
signiﬁcantly higher at 31 °C compared to 25 °C and 28 °C (p≤ .05). In
parallel to our observation, alteration in human serum survivability of
V. vulniﬁcus in response to ﬂuctuation in temperature was observed
Williams et al. (2014). This might explain the observation of Amaro
et al. (1995) that increase in infective capacity of V. vulniﬁcus at higher
temperature.
As the prevalence of V. vulniﬁcus was already demonstrated in
Indian waters (Thampuran and Surendran, 1998; Parvathy et al., 2004),
sea water and fouling of cage nets might be sources of infection in the
present case. V. vulniﬁcus outbreak in ﬁsh was found to be associated
with moderate shifts in water salinity and increased in water tem-
perature (Li et al., 2006). While the precipitating cause of disease
outbreak during the present investigation is still unknown, moderate
ﬂuctuation in salinity along with persistent high water temperature of
31 °C and high stocking density might have caused stress and disease in
present case also. One interesting observation in the outbreak was; al-
though it was a mixed cage farm with Pearl spots (Etroplus suratensis)
and mangrove red snappers (Lutjanus argentimaculatus), only tilapia ﬁsh
showed the clinical signs of infection and mortality. V. vulniﬁcus in-
fection associated with high stocking density stress was already re-
ported in tilapia (Plumb, 1999). In accordance with the present ob-
servation, V. vulniﬁcus infections were more reported in tilapia among
diﬀerent ﬁsh, next to eels. Species like Striped bass (Morone saxatilis),
Table 1
Antibiotic susceptibility test- results.
Sl No Class of
antimicrobials
Antibiotics Code (Number
indicates
concentration
in μg per disc)
Result of
antibiogram
(R- Resistant; I-
Intermediate;
S-Sensitive)
1 Penicillins Ampicillin AMP25 S
2 Piperacillin PI100 S
3 Cephalosporins Cefoxitin CK30 R
4 Cefuroxime CXM30 I
5 Cefoperazone CPZ75 S
6 Carbapenems Meropenem MRP10 S
7 Ertapenem ETP10 S
8 Imipenem IPM10 S
9 Aminoglycosides Kanamycin K30 S
10 Gentamicin GEN10 S
11 Streptomycin S10 S
12 Amikacin AK30 S
13 Quinolones Levoﬂoxacin LE5 S
14 Ciproﬂoxacin CF10 S
15 Lomeﬂoxacin LOM10 S
16 Norﬂoxacin NX10 S
17 Oﬂoxacin OF5 S
18 Nalidixic acid NA30 S
19 Tetracyclines Tetracycline TE30 S
20 Doxycycline DO30 S
21 Polypeptides Colistin CL10 R
22 Sulphonamides Co-Trimoxazole
(Sulpha/
Trimethoprim)
COT23.75/1.25 S
23 Others Chloramphenicol C30 S
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turbot (Scophthalmus maximus), sea bream (Sparus aurata) and trout
(Oncorhynchus mykiss), are reported to be less susceptible or resistant to
V. vulniﬁcus than tilapia (Biosca and Amaro, 1996). Therefore, the exact
reason for increased susceptibility of tilapia to V. vulniﬁcus has to be
thoroughly targeted in future studies.
To ascertain the zoonotic potential of the etiology, genetic typing
based on vvhA gene (Senoh et al., 2005) and ampliﬁcation of a variable
region located within pilF gene which is associated with potential
human pathogenicity (Roig et al., 2010) was further performed. Results
demonstrated that CMFRI/VV-02 belonged to vvhA genetic type 1, for
which human clinical strains are associated (Senoh et al., 2005). Ad-
ditionally, pilF polymorphism-based PCR showed that CMFRI/VV-02
strain may pose potential danger for humans. Therefore, we postulated
that V. vulniﬁcus infected tilapia can pose a public health risk. The
hypothesis is further supported by the case reports of V. vulniﬁcus in-
fections including septicaemia in humans after handling tilapia ﬁsh
species (Chan et al., 1999; Vinh et al., 2006; Zaidenstein et al., 2008)
To pave the way for further insights on the virulence nature, pre-
sence of various virulence features was screened. The presumed viru-
lence factors of V. vulniﬁcus primarily comprise iron acquisition sys-
tems, hemolysin, protease, capsule as well as polar and lateral ﬂagella
(Natividad-Bonifacio et al., 2013). The strain showed positive results in
all these ﬁve factors except protease. In agreement with this observa-
tion, Sakata and Hattori (1988) and Shao and Hor (2000) had suggested
that extracellular protease is not primary virulent factor in V. vulniﬁcus
for tilapia and mice respectively. The observed β haemolytic property
was correlated with vvhA detection, encoding a haemolysin with cyto-
lysin activity. The tested strain was positive for siderophore production,
by which the pathogen acquires iron during infection (Kim et al., 2008).
Presence of polar and lateral ﬂagella (swimming and swarming move-
ments) in the strain will help in the colonization during pathogenesis
(Natividad-Bonifacio et al., 2013). Capsule will help in resisting the
action of complements and act as a triggering factor for septicaemia and
lethality in V. vulniﬁcus infection (Shapiro et al., 1998).
Antimicrobial susceptibility tests showed that CMFRI/VV-02 was
resistant to only three antibiotics namely, Cefoxitin, Cefuroxime and
Colistin (out of 23 tested antibiotics) with MAR index of 0.13. The MAR
index of the strain (≤ 0.2) indicated that the strain has originated from
a low risk source of contamination with antibiotics (Paul et al., 1997).
Even though the strain was found to be susceptible to many tested
antibiotics, use of antibiotics against V. vulniﬁcus is not recommended.
As the continuous use of antibiotics could reduce their eﬃcacy and
promote the development of antibiotic resistant bacteria (Monteiro
et al., 2016), prophylactic management through development of an
eﬃcient vaccine or antagonistic feed represents the best strategy for
controlling the diseases in aquaculture/mariculture facilities.
5. Conclusions
The present paper described the pathological features of natural
outbreak by V. vulniﬁcus within a cage farm of tilapia ﬁsh in Indian
water for the ﬁrst time. The rapid growth rate of tilapia coupled with
high stocking density and increased water temperature could be the
precipitating causes for the outbreak. Results of challenge tests con-
ﬁrmed that V. vulniﬁcus could act as a primary pathogen for tilapia
reared in brackish water. pilF polymorphism-based PCR and vvhA gene
sequence of CMFRI/VV-02 strain indicated that V. vulniﬁcus infected
tilapia may pose a public health risk; and ﬁsh farmers should take ap-
propriate preventive measures during vibriosis episodes. Management
measures, including avoidance of overcrowding, prompt removal of
moribund ﬁsh, altering the interior net of the sea cage and its location
and providing shade, while the water temperature rises can be adopted.
At the same time, further study on prevalence and population structure
of V. vulniﬁcus in cage farms and development of proper prophylactic
management including an eﬃcient vaccine or antagonistic cum im-
muno-stimulant feed are recommended in future research.
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